Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03344861 · ClinicalTrials.gov registry record · Phase 1
Safety of PDT-Photofrin® Prior to Lung Surgery
A Phase 1 study, sponsored by Concordia Laboratories.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT03344861: Completed Phase 1 study, sponsored by Concordia Laboratories.
NCT03344861 is a Phase 1 study that has completed, run by Concordia Laboratories. The registered enrollment target is 10 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03344861, a Phase 1 study, has completed, sponsored by Concordia Laboratories.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
This research study is being conducted to assess the safety of PDT in subjects with peripherally located malignant tumors in lung parenchyma prior to surgical resection. It will involve up to 10 sites in USA. Participation will last 4 months.
Primary Outcome
Safety evaluation will include incidence of all adverse events, including serious and non-serious. The count of how many subjects experienced at least one adverse event.
Interventions
- DRUG Porfimer Sodium
- DEVICE Fiber optic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2017-08-14 |
| Est. Completion | 2019-03-22 |
| Phase | Phase 1 |
What the finished NCT03344861 record still lists
NCT03344861 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 2 interventions - of which Porfimer Sodium is the first listed.
NCT03344861 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03344861 about?
NCT03344861 is a clinical study titled "Safety of PDT-Photofrin® Prior to Lung Surgery". This research study is being conducted to assess the safety of PDT in subjects with peripherally located malignant tumors in lung parenchyma prior to surgical resection. It will involve up to 10 sites in USA. Participation will last 4 months.
What is the current status of trial NCT03344861?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2017-08-14. Estimated completion is 2019-03-22.
What interventions are being tested in trial NCT03344861?
The interventions under investigation include: Porfimer Sodium (DRUG), Fiber optic (DEVICE).
Who is sponsoring clinical trial NCT03344861?
This trial is sponsored by Concordia Laboratories, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03344861's enrollment target sits among peer trials
10 1913th of 2000 higher than 46 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI